Comprehensive analysis to identify DLEU2L/TAOK1 axis as a prognostic biomarker in hepatocellular carcinoma

Yi Shi; Dan Dan Zhang; Ji Bin Liu; Xiao Li Yang; Rui Xin; Cheng You Jia; Hui Min Wang; Gai Xia Lu; Pei Yao Wang; Yu Liu; Zi Jin Li; Jing Deng; Qin Lu Lin; Liang Ma; Shan Shan Feng; Xiao Qi Chen; Xiang Min Zheng; Ya Fu Zhou; Yong Jun Hu; Hua Qun Yin; Lin Lin Tian; Li Peng Gu; Zhong Wei Lv; Fei Yu; Wen Li; Yu Shui Ma; Fu Da

doi:10.1016/j.omtn.2020.12.016

Comprehensive analysis to identify DLEU2L/TAOK1 axis as a prognostic biomarker in hepatocellular carcinoma

Yi Shi
, Dan Dan Zhang
, Ji Bin Liu
, Xiao Li Yang
, Rui Xin
, Cheng You Jia
, Hui Min Wang
, Gai Xia Lu
, Pei Yao Wang
, Yu Liu
, Zi Jin Li
, Jing Deng
, Qin Lu Lin
, Liang Ma
, Shan Shan Feng
, Xiao Qi Chen
, Xiang Min Zheng
, Ya Fu Zhou
, Yong Jun Hu
, Hua Qun Yin

Lin Lin Tian, Li Peng Gu, Zhong Wei Lv, Fei Yu, Wen Li^*, Yu Shui Ma^*, Fu Da^*

^*Corresponding author for this work

Central South University of Forestry & Technology
Nantong Tumor Hospital
Hunan University of Technology
Shihezi University
Tongji University
Hunan Normal University
Central South University
Fudan University

Research output: Contribution to journal › Article › peer-review

38 Scopus citations

Abstract

Shi et al. provide evidence that a ceRNA-based DLEU2L/TAOK1 axis has an impact on changes in the tumor immune microenvironment and might be a novel important prognostic factor associated with the diagnosis and prognosis of HCC.

Original language	English
Pages (from-to)	702-718
Number of pages	17
Journal	Molecular Therapy Nucleic Acids
Volume	23
DOIs	https://doi.org/10.1016/j.omtn.2020.12.016
State	Published - 5 Mar 2021
Externally published	Yes

Keywords

DLEU2L/TAOK1 axis
HCC
ceRNA network
prognosis

Access to Document

10.1016/j.omtn.2020.12.016

Cite this

Shi, Y., Zhang, D. D., Liu, J. B., Yang, X. L., Xin, R., Jia, C. Y., Wang, H. M., Lu, G. X., Wang, P. Y., Liu, Y., Li, Z. J., Deng, J., Lin, Q. L., Ma, L., Feng, S. S., Chen, X. Q., Zheng, X. M., Zhou, Y. F., Hu, Y. J., ... Da, F. (2021). Comprehensive analysis to identify DLEU2L/TAOK1 axis as a prognostic biomarker in hepatocellular carcinoma. Molecular Therapy Nucleic Acids, 23, 702-718. https://doi.org/10.1016/j.omtn.2020.12.016

@article{0175f816354d45f58ba57720272b1d9d,

title = "Comprehensive analysis to identify DLEU2L/TAOK1 axis as a prognostic biomarker in hepatocellular carcinoma",

abstract = "Shi et al. provide evidence that a ceRNA-based DLEU2L/TAOK1 axis has an impact on changes in the tumor immune microenvironment and might be a novel important prognostic factor associated with the diagnosis and prognosis of HCC.",

keywords = "DLEU2L/TAOK1 axis, HCC, ceRNA network, prognosis",

author = "Yi Shi and Zhang, \{Dan Dan\} and Liu, \{Ji Bin\} and Yang, \{Xiao Li\} and Rui Xin and Jia, \{Cheng You\} and Wang, \{Hui Min\} and Lu, \{Gai Xia\} and Wang, \{Pei Yao\} and Yu Liu and Li, \{Zi Jin\} and Jing Deng and Lin, \{Qin Lu\} and Liang Ma and Feng, \{Shan Shan\} and Chen, \{Xiao Qi\} and Zheng, \{Xiang Min\} and Zhou, \{Ya Fu\} and Hu, \{Yong Jun\} and Yin, \{Hua Qun\} and Tian, \{Lin Lin\} and Gu, \{Li Peng\} and Lv, \{Zhong Wei\} and Fei Yu and Wen Li and Ma, \{Yu Shui\} and Fu Da",

note = "Publisher Copyright: {\textcopyright} 2020 The Author(s)",

year = "2021",

month = mar,

day = "5",

doi = "10.1016/j.omtn.2020.12.016",

language = "英语",

volume = "23",

pages = "702--718",

journal = "Molecular Therapy Nucleic Acids",

issn = "2162-2531",

publisher = "Cell Press",

}

Shi, Y, Zhang, DD, Liu, JB, Yang, XL, Xin, R, Jia, CY, Wang, HM, Lu, GX, Wang, PY, Liu, Y, Li, ZJ, Deng, J, Lin, QL, Ma, L, Feng, SS, Chen, XQ, Zheng, XM, Zhou, YF, Hu, YJ, Yin, HQ, Tian, LL, Gu, LP, Lv, ZW, Yu, F, Li, W, Ma, YS & Da, F 2021, 'Comprehensive analysis to identify DLEU2L/TAOK1 axis as a prognostic biomarker in hepatocellular carcinoma', Molecular Therapy Nucleic Acids, vol. 23, pp. 702-718. https://doi.org/10.1016/j.omtn.2020.12.016

TY - JOUR

T1 - Comprehensive analysis to identify DLEU2L/TAOK1 axis as a prognostic biomarker in hepatocellular carcinoma

AU - Shi, Yi

AU - Zhang, Dan Dan

AU - Liu, Ji Bin

AU - Yang, Xiao Li

AU - Xin, Rui

AU - Jia, Cheng You

AU - Wang, Hui Min

AU - Lu, Gai Xia

AU - Wang, Pei Yao

AU - Liu, Yu

AU - Li, Zi Jin

AU - Deng, Jing

AU - Lin, Qin Lu

AU - Ma, Liang

AU - Feng, Shan Shan

AU - Chen, Xiao Qi

AU - Zheng, Xiang Min

AU - Zhou, Ya Fu

AU - Hu, Yong Jun

AU - Yin, Hua Qun

AU - Tian, Lin Lin

AU - Gu, Li Peng

AU - Lv, Zhong Wei

AU - Yu, Fei

AU - Li, Wen

AU - Ma, Yu Shui

AU - Da, Fu

PY - 2021/3/5

Y1 - 2021/3/5

N2 - Shi et al. provide evidence that a ceRNA-based DLEU2L/TAOK1 axis has an impact on changes in the tumor immune microenvironment and might be a novel important prognostic factor associated with the diagnosis and prognosis of HCC.

AB - Shi et al. provide evidence that a ceRNA-based DLEU2L/TAOK1 axis has an impact on changes in the tumor immune microenvironment and might be a novel important prognostic factor associated with the diagnosis and prognosis of HCC.

KW - DLEU2L/TAOK1 axis

KW - HCC

KW - ceRNA network

KW - prognosis

UR - https://www.scopus.com/pages/publications/85100060856

U2 - 10.1016/j.omtn.2020.12.016

DO - 10.1016/j.omtn.2020.12.016

M3 - 文章

AN - SCOPUS:85100060856

SN - 2162-2531

VL - 23

SP - 702

EP - 718

JO - Molecular Therapy Nucleic Acids

JF - Molecular Therapy Nucleic Acids

ER -

Comprehensive analysis to identify DLEU2L/TAOK1 axis as a prognostic biomarker in hepatocellular carcinoma

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this